Tutorials › Optimal Design and Model-Informed Dosing › Distribution-Phase Sampling in Two-Compartment PK

Optimal Sampling for Individual PK Models · Tutorial 43 of 497

Distribution-Phase Sampling in Two-Compartment PK

Learn to place sparse samples across the fast distribution and slower terminal phases, and to recognize what each sampling window can—and cannot—identify.

Advanced 10 min read

What You'll Learn

  • Write the biexponential concentration profile for a linear two-compartment IV bolus model.
  • Distinguish the fast distribution-related component from the terminal component without equating either rate with a single micro-rate constant.
  • Calculate when the two exponential components contribute equally and how the apparent slope changes over time.
  • Use parameter sensitivities to explain why samples from different phases can be informative.
  • Diagnose schedules that cluster samples in one phase or contain too few observations for the parameters of interest.
  • Compare phase-spanning sampling with early-only and terminal-only schedules.

Why Sampling Time Matters

After an IV bolus, a two-compartment concentration profile does not generally decline at one constant rate. The observed concentration reflects both a relatively rapid distribution-related change and a slower terminal decline. A sparse schedule concentrated in only one time window can therefore describe one part of the profile well while providing little information about another. The design question here is how to distribute samples so that central distribution, intercompartmental exchange, and terminal elimination leave distinguishable signatures in the measurements.

“Distribution phase” is a useful description of the early, rapidly changing part of the profile, not a claim that one observed exponential corresponds only to transfer between compartments. The exponential rates are hybrid quantities determined by several underlying rate constants. Sampling across phases helps separate their effects; it does not make every physiological parameter identifiable automatically.

Model and Meaning of the Phases

For a linear, time-invariant two-compartment model after an instantaneous IV bolus, write the central concentration as a sum of two exponentials:

$$ C(t)=A e^{-\alpha t}+B e^{-\beta t}, \qquad t\geq 0,\quad \alpha>\beta>0. $$

Here \(C(t)\) is concentration at time \(t\), \(A\) and \(B\) are positive concentration coefficients, and \(\alpha\) and \(\beta\) are positive rate constants. Time and rate units must be compatible: if time is in hours, the rates are in inverse hours. The term with rate \(\alpha\) declines faster and is called the fast component; the term with rate \(\beta\) declines more slowly and governs the terminal slope when the fast contribution has become negligible.

Definition: In this tutorial, distribution-phase sampling means collecting early post-bolus concentrations while the fast component contributes materially to the observed profile. Terminal-phase sampling means collecting later concentrations after the fast contribution is small enough that the slow component dominates. The transition between these regions is gradual, not a sharp physiological boundary.

For the standard mammillary model, let \(k_{10}\) be the first-order elimination rate from the central compartment, \(k_{12}\) the transfer rate from central to peripheral, and \(k_{21}\) the transfer rate from peripheral to central. These micro-rate constants are not interchangeable with \(\alpha\) and \(\beta\). The two macro-rates are the roots of

$$ \lambda^2-(k_{10}+k_{12}+k_{21})\lambda+k_{10}k_{21}=0. $$

The larger root is \(\alpha\), and the smaller root is \(\beta\). Thus both observed phases depend on the underlying elimination and exchange processes. In particular, the terminal rate \(\beta\) is not generally equal to \(k_{10}\), and the fast rate \(\alpha\) is not a direct measurement of \(k_{12}\).

The model assumes linear first-order disposition, a bolus that is effectively instantaneous relative to the sampling window, known dose and sampling times, and a suitable model for measurement error. The biexponential representation also assumes that concentrations follow the same parameter values throughout observation. A prolonged input, time-varying clearance, nonlinear elimination, or incorrect compartment structure can make phase-based interpretation misleading. Samples taken before mixing is adequately represented by the model should not be treated as ordinary post-bolus observations.

How the Apparent Decline Changes

The relative contribution of the fast component decreases over time. Equating the two terms gives the time at which their contributions are equal:

$$ A e^{-\alpha t_*}=B e^{-\beta t_*} \quad\Longrightarrow\quad t_*=\frac{\log(A/B)}{\alpha-\beta}, $$

provided this time is nonnegative. This calculation is a model-based guide to a transition window, not a universal rule for when to collect samples. The useful window also depends on assay precision, feasible sampling times, and the parameters the design is intended to inform.

The instantaneous apparent decline rate is the negative derivative of log concentration. Differentiating the profile yields

$$ -\frac{d\log C(t)}{dt} = \frac{\alpha A e^{-\alpha t}+\beta B e^{-\beta t}} {A e^{-\alpha t}+B e^{-\beta t}}. $$

This is a concentration-weighted average of \(\alpha\) and \(\beta\), so it lies between them. As time increases, the weight on the fast component falls and the apparent decline rate approaches \(\beta\). This explains why a late log-concentration plot can look nearly linear even though the full profile was not a single exponential.

Worked Example: Locating the Component Crossover

Consider a hypothetical profile with concentration in mg/L, time in hours, and rates in h\(^{-1}\):

$$ C(t)=5e^{-2t}+2e^{-0.2t}. $$

The fast and slow terms are equal when

$$ t_*=\frac{\log(5/2)}{2-0.2} =\frac{0.916291}{1.8} =0.5091\text{ h}. $$

At 0.5 h, the fast contribution is \(5e^{-1}=1.839\) mg/L and the slow contribution is \(2e^{-0.1}=1.810\) mg/L. Their sum is \(3.649\) mg/L, so the fast fraction is \(1.839/3.649=0.504\), or 50.4%. The model therefore places the crossover close to 0.5 h.

At 3 h, the fast contribution is \(5e^{-6}=0.01239\) mg/L, while the slow contribution is \(2e^{-0.6}=1.098\) mg/L. The total is \(1.110\) mg/L, and only about \(0.01239/1.110=1.12\%\) is fast. A sample near 3 h would mainly reflect the terminal component, whereas a sample near 0.5 h would capture both components. These predictions suggest sampling windows; they do not establish that the assumed model is correct.

Designing a Sparse Schedule Across Phases

A useful sparse schedule includes early post-bolus observations, observations near the period when both components contribute, and later observations after the fast component has weakened. The precise times should be based on plausible parameter values and the intended estimation task. If the fast rate is high, the early window may be brief; if the rates are closer together, the transition can be more gradual. An early sample must be late enough for the model and assay to be valid, but early enough to retain information about rapid change.

The role of a sample can also be described using sensitivities. For the parameterization \((A,\alpha,B,\beta)\), the derivatives of concentration are

$$ \frac{\partial C}{\partial A}=e^{-\alpha t},\qquad \frac{\partial C}{\partial \alpha}=-At e^{-\alpha t},\qquad \frac{\partial C}{\partial B}=e^{-\beta t},\qquad \frac{\partial C}{\partial \beta}=-Bt e^{-\beta t}. $$

An early observation can be sensitive to the fast coefficient and rate, while a late one has little sensitivity to \(\alpha\) once \(e^{-\alpha t}\) is tiny. Conversely, a very early sample has little leverage on \(\beta\), because the slow exponential has changed little from its initial value. In an individual-model design with independent errors of known variance, the sensitivities at the chosen times form rows of a sensitivity matrix; information depends on their magnitudes and whether their patterns distinguish the parameters. This is why merely adding observations at nearly identical times may add little new information.

Worked Example: Comparing Sensitivity Patterns

Use the hypothetical profile \(C(t)=5e^{-2t}+2e^{-0.2t}\) and consider derivatives with respect to log-parameters \((\log A,\log\alpha,\log B,\log\beta)\). A derivative with respect to a log-parameter is the corresponding ordinary derivative multiplied by that parameter. At \(t=0.1\) h, the fast and slow contributions are \(4.09365\) and \(1.96040\) mg/L, respectively. The sensitivity row is therefore

$$ \left( 4.09365,\; -2(0.1)(4.09365),\; 1.96040,\; -0.2(0.1)(1.96040) \right) = (4.09365,-0.81873,1.96040,-0.03921). $$

At \(t=3\) h, the contributions are \(0.01239\) and \(1.09762\) mg/L, giving

$$ \left( 0.01239,\; -2(3)(0.01239),\; 1.09762,\; -0.2(3)(1.09762) \right) \approx(0.01239,-0.07437,1.09762,-0.65857). $$

The late row has almost no sensitivity to the fast rate, while its sensitivity to the slow rate is substantial. The early row has a strong fast-component contribution and very little slow-rate sensitivity. Together they illustrate why observations separated across phases can contribute different information. Two observations alone cannot determine four freely varying parameters; a practical design needs enough observations and sufficiently distinct sensitivity patterns, with checks for conditioning and uncertainty.

Worked Example: Checking a Candidate Four-Time Schedule

Suppose a hypothetical investigator can collect four post-bolus samples and considers \(0.1,\;0.5,\;1,\) and \(3\) h for the profile above. At 0.1 h, the concentration is \(4.09365+1.96040=6.05405\) mg/L, with 67.6% from the fast term. At 0.5 h, it is 3.64907 mg/L, with 50.4% fast. At 1 h,

$$ C(1)=5e^{-2}+2e^{-0.2} =0.676676+1.637462 =2.314138\text{ mg/L}. $$

The fast fraction at 1 h is \(0.676676/2.314138=0.2924\), or 29.2%. At 3 h it is only 1.12%, as calculated above. The schedule thus spans a fast-dominated observation, the crossover region, a mixed later observation, and a terminal-dominated observation.

Four observations are only the algebraic minimum for estimating four unconstrained parameters from four scalar measurements; they do not guarantee stable estimation in the presence of error. The investigator would still need to evaluate the sensitivity matrix and the assumed error model. Replication or additional times may be needed for precision and diagnostics. The calculation supports the phase coverage of this candidate schedule, not a claim that it is universally optimal.

Diagnostics, Alternatives, and Limitations

Several warning signs indicate that a phase-spanning design or its model assumptions may be failing:

  • Only late samples are available. The fast term may be negligible at every observed time, leaving little direct information about rapid distribution-related behavior.
  • All samples are clustered early. A terminal slope may be poorly characterized if observations do not reach a period where the slow component dominates.
  • Sampling times are too similar. The sensitivity rows may be nearly redundant, even when there are many measurements.
  • Early observations disagree systematically with the biexponential profile. Check bolus timing, mixing, assay behavior, and whether the assumed model adequately describes the data before interpreting the mismatch as unusual distribution.
  • Late concentrations are near or below quantification limits. Nominally terminal samples may contribute little usable information; a proposed time must be considered alongside measurement capability.

The main alternative is not simply “early” versus “late,” but a schedule chosen for a different objective. Early-only sampling may be adequate when the target is restricted to initial exposure or rapid behavior and other parameters are known or constrained. Terminal-only sampling can be appropriate when the terminal decline is the principal target, but it cannot by itself recover information that has disappeared with the fast term. A phase-spanning schedule is the natural starting point when the goal is to distinguish both components. Formal design criteria and numerical search can refine candidate times, but they cannot compensate for an incorrect model or an uninformative observation window.

A common mistake is to call \(\alpha\) “the distribution rate” and \(\beta\) “the elimination rate,” then assume one early and one late observation identify the corresponding physiological processes. The correction is that both macro-rates depend on multiple micro-rate constants, and observations inform parameters through the complete profile and its sensitivities. Another mistake is to treat the time of equal component contributions as a mandatory sample time. It is a useful reference point, but the best feasible times depend on the model, error, and estimand.

Key takeaway: To distinguish distribution-related and terminal behavior, place observations where the fast component is still visible, where the two components overlap, and where the slow component dominates. Then check that the resulting sensitivity patterns and data quality support the parameters you intend to estimate.

Check Your Understanding

Answer each question, then compare with the solutions below.

  1. For \(C(t)=4e^{-1.5t}+1e^{-0.15t}\), calculate the time when the exponential components are equal.
  2. In the worked profile \(5e^{-2t}+2e^{-0.2t}\), calculate the total concentration and fast-component fraction at 1 h.
  3. Why can a sample collected only at a late time provide little information about \(\alpha\)?
  4. True or false: in the standard two-compartment model, the terminal rate \(\beta\) is always equal to the central elimination rate \(k_{10}\). Explain.

Solutions. (1) \(t_*=\log(4/1)/(1.5-0.15)=1.38629/1.35=1.027\) h. (2) \(C(1)=5e^{-2}+2e^{-0.2}=0.676676+1.637462=2.314138\) mg/L; the fast fraction is \(0.676676/2.314138=0.2924\), or 29.2%. (3) At late times \(e^{-\alpha t}\) is very small, so both the fast contribution and its sensitivity to \(\alpha\) are small. (4) False. \(\beta\) is an eigenvalue determined by the combination of elimination and intercompartmental exchange rates, not generally \(k_{10}\) alone.

Clinical Biostats